CG
TMDX icon

Cutler Group’s Transmedics TMDX Stock Holding History

Cutler Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,700
Closed -$25K – 6043
2021
Q4 		$25K Sell
2,700
-900
-25% -$22.6K ﹤0.01% 2959
2021
Q3 		$14K Buy
3,600
+300
+9% +$9.17K ﹤0.01% 3668
2021
Q2 		$20K Buy
3,300
+2,000
+154% +$55.4K ﹤0.01% 3309
2021
Q1 		$12K Buy
+1,300
New +$40K ﹤0.01% 3675

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Cutler Group's TMDX Position: Q4 2023 in Review

Cutler Group sold out of Transmedics (TMDX) in Q4 2023, closing a stake of 700 shares — an estimated $38K sold.

Cutler Group first reported a position in TMDX in Q2 2021 and held it in 7 quarters. The position peaked at $218K in Q3 2021. 248 funds tracked by Wall St. Rank hold TMDX as of Q4 2023.

  • Cutler Group reported no remaining Transmedics position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 700 Transmedics shares in Q4 2023, an estimated $38K.
  • Cutler Group first reported a position in Transmedics in Q2 2021 and held it in 7 quarters.
  • Cutler Group's Transmedics position peaked at $218K in Q3 2021.
  • 248 funds tracked by Wall St. Rank held Transmedics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.